Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

Date

Authors

Jordana B. Cohen

Thomas C. Hanff

Preethi William

Nancy K. Sweitzer

Nelson R. Rosado‐Santander

Juan E. Rodriguez‐Mori

Vicente Corrales‐Medina

Publisher

Elsevier BV

Description

Citaciones: 223

Keywords

Discontinuation, Medicine, Coronavirus disease 2019 (COVID-19), Renin–angiotensin system, Open label, 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Prospective cohort study, Clinical trial, Internal medicine

DOI

10.1016/s2213-2600(20)30558-0

URI

https://doi.org/10.1016/s2213-2600(20)30558-0
https://andeanlibrary.org/handle/123456789/43130

Collections

Artículo Científico Publicado